Gustave Roussy, Cancer Campus, Grand Paris
Gustave Roussy, Cancer Campus, Grand Paris
Explore linked clinical trials.93 results · Page 1 of 4
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Prospective Analysis of Circulating Nucleosomes in Patients Receiving a First Line Treatment for a Non-Hodgkin Lymphoma | B-cell neoplasm, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, diffuse large B-cell lymphoma, follicular lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm | Active, not recruiting | Not applicable | 2026-10-05 | NCT06813573 | |
| Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, endometrium neoplasm, female reproductive system disorder, female reproductive system neoplasm, neoplasm, uterine disorder | Recruiting | Phase 2 | 2026-09-24 | NCT05640999 | |
| Evaluation of the Efficacy and Safety of Neoadjuvant Therapy in Patients With Surgically Resectable Pancreatic Adenocarcinoma. | ECOG Performance Status Score of 0 or 1; Non Metastatic; Pancreatic Adenocarcinoma Resectable | Not yet recruiting | Phase 2 | 2026-09-15 | NCT07808567 | |
| Doxorubicin With or Without DT-7012 in Advanced Soft Tissue Sarcoma | Neoplasms by Histologic Type, Neoplasms, Adipose Tissue, Neoplasms, Connective and Soft Tissue, Neoplasms, Fibrous Tissue, connective tissue neoplasm, histiocytoma, liposarcoma, neoplasm, sarcoma, undifferentiated pleomorphic sarcoma | Not yet recruiting | Phase 2 | 2026-09-15 | NCT07802652 | |
| MoleculAr Profiling for Pediatric and Young Adult Cancer Treatment Stratification 2 | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, hematologic disorder, leukemia, neoplasm | Recruiting | Not applicable | 2026-09-14 | NCT05691608 | |
| Iatrogenic Effects of Treatment for Childhood Cancer Constitution of a Biological Samples Bank | Paediatric Malignancies | Recruiting | Not stated | 2026-09-10 | NCT02666625 | |
| Study Investigating Tarlatamab (AMG 757) in Patients With Metastatic/Locally Advanced Small-Cell Lung Cancer (SCLC) and Other Poorly Differentiated Neuroendocrine Carcinomas (NECs), With Biomarker Analysis to Characterize Response/Resistance (UNLOCK TARLATAMAB) | Neoplasm Metastasis, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, neoplasm | Recruiting | Phase 2 | 2026-09-09 | NCT07016230 | |
| Dose-Expansion Modular Study To Explore the Safety, Tolerability, and Anti-tumor Activity of HER3- DXd Monotherapy and Combinations in Patients With Inoperable Advanced Breast Cancer (ABC) After Progression on T-DXd | Advanced Breast Cancer; Breast Cancer Metastatic; HER2 Low Breast Carcinoma; HER2-positive Metastatic Breast Cancer | Recruiting | Phase 1 / Phase 2 | 2026-09-04 | NCT06298084 | |
| Innovative and Cooperative Pathway Integrating Oncogeriatric, Pharmaceutical and Pharmacological Follow-up in Elderly Patients. | Digestive System Diseases, Digestive System Neoplasms, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Male Urogenital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Connective and Soft Tissue, Skin and Connective Tissue Diseases, Thoracic Neoplasms, Urogenital Diseases, Urogenital Neoplasms, benign urinary system neoplasm, breast cancer, breast disorder, breast neoplasm, colonic disorder, colonic neoplasm, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, kidney cancer, kidney disorder, lung cancer, lung disorder, lung neoplasm, male reproductive organ cancer, male reproductive system disorder, malignant colon neoplasm, neoplasm, prostate cancer, prostate disorder, respiratory system disorder, respiratory tract neoplasm, sarcoma, skin disorder, urinary system disorder | Not yet recruiting | Phase 4 | 2026-09-03 | NCT07802847 | |
| Study Investigating the Safety of Anti-CD19 CAR-T Cells Therapy Produced at Gustave Roussy for Adults With Severe and Refractory Systemic Autoimmune Rheumatic Diseases | Skin and Connective Tissue Diseases, arthritic joint disease, arthropathy, autoimmune disease, connective tissue disorder, immune system disorder, muscle tissue disorder, musculoskeletal system disorder, myositis disease, nervous system disorder, neuromuscular disease, rheumatic disorder, rheumatoid arthritis, skin disorder, systemic lupus erythematosus, systemic sclerosis | Not yet recruiting | Phase 1 | 2026-09-02 | NCT07544225 | |
| Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication 2.0 | Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, brain disorder, brainstem cancer, central nervous system cancer, central nervous system disorder, diffuse intrinsic pontine glioma, diffuse midline glioma, H3 K27M-mutant, epithelial neoplasm, glioma, neoplasm, nervous system disorder, neuroepithelial neoplasm, primitive neuroectodermal tumor | Recruiting | Phase 3 | 2026-08-13 | NCT05476939 | |
| Preliminary Clinical Feasibility Study of a Medical Device Enabling Brain Access Using Microbubble-Enhanced Sonication | Brain Metastases From Extra-cranial Solid Tumors; Recurrent Grade 4 Glioma | Not yet recruiting | Phase 1 | 2026-08-10 | NCT07754006 | |
| Study Investigating ASP3082 in Patients With Metastatic/Locally Advanced Non-small-cell Lung Cancer (NSCLC) and Pancreatic Ductal Adenocarcinoma (PDAC), With Biomarker Analysis to Characterize Response/Resistance | Neoplasm Metastasis, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, neoplasm | Recruiting | Phase 2 | 2026-08-05 | NCT07483983 | |
| Short-term Pre-OPerative Durvalumab (MEDI 4736) in Early Small Triple Negative Breast Cancer Patients (POP-Durva) | Brain Damage, Chronic, Neoplasms by Site, Skin and Connective Tissue Diseases, brain disorder, breast disorder, breast neoplasm, central nervous system disorder, cerebral palsy, neoplasm, nervous system disorder, skin disorder, triple-negative breast carcinoma | Active, not recruiting | Phase 2 | 2026-08-05 | NCT05215106 | |
| Health Effects of CArdiac FluoRoscopy and MOderN RadIotherapy in PediatriCs - Radiotherapy | Neoplasms, Radiation-Induced, injury, neoplasm, radiation injury | Recruiting | Not stated | 2026-08-03 | NCT04746729 | |
| Patient Reported Outcome Measurement Within the Secured Access to Innovative Medicines for Children With cAncer (SACHA) Study | Neoplasms by Site, central nervous system cancer, neoplasm, nervous system disorder | Not yet recruiting | Not stated | 2026-07-31 | NCT07738601 | |
| Investigation of Tumour Spectrum of Germline Mutations in Breast and Ovarian Cancer Genes. | Adnexal Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Skin and Connective Tissue Diseases, Urogenital Diseases, Urogenital Neoplasms, breast disorder, breast neoplasm, endocrine system disorder, female reproductive system disorder, female reproductive system neoplasm, gonadal disorder, hereditary breast ovarian cancer syndrome, hereditary disease, hereditary neoplastic syndrome, malignant endocrine neoplasm, neoplasm, ovarian cancer, ovarian disorder, skin disorder | Active, not recruiting | Not applicable | 2026-07-31 | NCT03246841 | |
| Pembrolizumab and Chemotherapy Treatment or no Treatment Guided by the Level of TILs in Resected Early-stage TNBC | Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder, triple-negative breast carcinoma | Recruiting | Phase 2 | 2026-07-24 | NCT06078384 | |
| European Proof-of-Concept Therapeutic Stratification Trial of Molecular Anomalies in Relapsed or Refractory Tumors | childhood malignant neoplasm, neoplasm | Recruiting | Phase 1 / Phase 2 | 2026-07-10 | NCT02813135 | |
| Prospective Multicenter Study Evaluating Feasibility and Efficacy of Tumor Organoid-based Precision Medicine in Patients With Advanced Refractory Cancers | Advanced, Pretreated Solid Tumors | Recruiting | Not applicable | 2026-06-26 | NCT05267912 | |
| The French E3N Prospective Cohort Study | Crohn disease, Digestive System Diseases, Digestive System Neoplasms, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Head and Neck Neoplasms, Hypersensitivity, Immediate, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Nutritional and Metabolic Diseases, Parkinson disease, Respiratory Hypersensitivity, Skin and Connective Tissue Diseases, Urogenital Diseases, Urogenital Neoplasms, asthma, basal ganglia disorder, brain disorder, breast cancer, breast disorder, breast neoplasm, bronchial disorder, cardiovascular disorder, central nervous system disorder, colonic disorder, colonic neoplasm, colorectal neoplasm, depressive disorder, diabetes mellitus, digestive system disorder, digestive system neoplasm, endocrine system disorder, endometriosis, endometrium neoplasm, female reproductive system disorder, female reproductive system neoplasm, gastroenteritis, glucose metabolism disease, hypertensive disorder, immune system disorder, inflammatory bowel disease, intestinal disorder, lung disorder, malignant endocrine neoplasm, melanocytic neoplasm, melanoma, metabolic disease, movement disorder, neoplasm, nervous system disorder, neurodegenerative disease, neuroendocrine neoplasm, obstructive lung disease, parkinsonian disorder, primitive neuroectodermal tumor, respiratory system disorder, skin disorder, skin neoplasm, synucleinopathy, thyroid gland disorder, thyroid tumor, uterine disorder, vascular disorder | Active, not recruiting | Not stated | 2026-06-25 | NCT03285230 | |
| Bevacizumab-based Chemotherapy Adapted to Bevacizumab Pharmacokinetics in 1st-line Treatment | Unresectable Metastatic Colorectal Cancer | Recruiting | Phase 3 | 2026-06-16 | NCT06642844 | |
| KORTUC (KRC-01) Plus Radiotherapy for Organ Preservation in Rectal Cancer | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm, rectal cancer, rectal disorder, rectal neoplasm | Not yet recruiting | Phase 2 | 2026-06-02 | NCT07622017 | |
| Cohort of Patients With Chronic Myelomonocytic Leukemia | Chronic Disease, Disease Attributes, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, bone marrow disorder, chronic myelomonocytic leukemia, hematologic disorder, leukemia, myelodysplastic/myeloproliferative disease, myeloid leukemia, neoplasm | Recruiting | Not stated | 2026-05-19 | NCT07512882 | |
| Adjuvant Trial in Pancreatic Neuroendocrine Tumors | Pancreatic Neuroendocrine Tumors; Pancreatic Neuroendocrine Tumors (pNET) | Not yet recruiting | Phase 3 | 2026-05-15 | NCT07591493 |